You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 2, 2024

CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Calcipotriene And Betamethasone Dipropionate patents expire, and what generic alternatives are available?

Calcipotriene And Betamethasone Dipropionate is a drug marketed by Glenmark Pharms Ltd, Chartwell Rx, Padagis Israel, Cosette, and Taro. and is included in five NDAs.

The generic ingredient in CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE is betamethasone dipropionate; calcipotriene. There are sixty-six drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the betamethasone dipropionate; calcipotriene profile page.

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE?
  • What are the global sales for CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE?
  • What is Average Wholesale Price for CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE?
Summary for CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE
Drug patent expirations by year for CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE
Recent Clinical Trials for CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
University of Alabama at BirminghamPhase 4
Eli Lilly and CompanyPhase 4
Celgene CorporationPhase 4

See all CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE clinical trials

Pharmacology for CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE

US Patents and Regulatory Information for CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Glenmark Pharms Ltd CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE betamethasone dipropionate; calcipotriene AEROSOL, FOAM;TOPICAL 214688-001 Mar 21, 2023 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Cosette CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE betamethasone dipropionate; calcipotriene SUSPENSION;TOPICAL 210765-001 May 11, 2020 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Chartwell Rx CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE betamethasone dipropionate; calcipotriene OINTMENT;TOPICAL 201615-001 Jan 14, 2013 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Padagis Israel CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE betamethasone dipropionate; calcipotriene OINTMENT;TOPICAL 200174-001 Dec 12, 2014 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Taro CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE betamethasone dipropionate; calcipotriene SUSPENSION;TOPICAL 213269-001 Sep 2, 2020 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.